Masimo Corp. Stock
Price
Target price
€139.15
€139.15
-0.140%
-0.2
-0.140%
€172.13
16:41 / Tradegate
WKN: 578074 / Symbol: MASI / Name: Masimo / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Masimo Corp. Stock
Masimo Corp. shows a slight decrease today, losing -€0.200 (-0.140%) compared to yesterday.
Masimo Corp. is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 172 € shows a positive potential of 23.61% compared to the current price of 139.15 € for Masimo Corp..
Pros and Cons of Masimo Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Masimo Corp. | -0.140% | -2.518% | -2.484% | 35.686% | -15.056% | 11.169% | -28.170% |
Haemonetics Corp. | -3.760% | -0.775% | 7.563% | -21.951% | -15.232% | 1.587% | -17.419% |
Merit Medical Systems | -1.880% | 2.564% | 0.629% | 0.629% | -12.568% | 58.416% | 102.020% |
Icu Medical Inc. | -3.450% | 1.754% | 1.754% | 0.000% | -21.088% | -27.044% | -29.268% |
Comments
Masimo Corporation (NASDAQ: MASI) had its "buy" rating re-affirmed by analysts at BTIG Research.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its price target lowered by analysts at Raymond James from $204.00 to $185.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $200.00 price target on the stock, down previously from $215.00.
Show more
Ratings data for MASI provided by MarketBeat
News

Masimo Tops EPS, Revenue Expectations
Masimo (NASDAQ:MASI), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong